Avenue Therapeutics Inc (ATXI)

Panoramica Notizia Cronologia dei prezzi Financials Perché ATXI Giù? Forum Previsione Frazionamento azionario

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	143.58% 2.392	0.982	0.907	3.027	1.215
Operating Income/Loss	74.99% -3.708	-2.119	-2.068	-3.923	-6.429
Nonoperating Income/Loss	-0.641	-	2.581	-0.093	-1.173
Income/Loss From Continuing Operations Before Tax	804.86% -4.349	0.617	0.513	-4.016	-7.602
Income/Loss From Continuing Operations After Tax	804.86% -4.349	0.617	0.513	-4.016	-7.602
Net Income/Loss	804.86% -4.349	0.617	0.513	-4.016	-7.602
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	60.87% -0.009	-0.023	-0.013	-0.009	-0.066
Basic Average Shares	83.65% 0.562	3.4366	8.1142	-	5.5648
Basic Earnings Per Share	2,850% -15.40	0.56	0.06	-0.52	-1.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$38.56

5.44%

GMAB

$28.66

0.62%

INCY

$105.98

0.70%

BNTX

$103.14

0.20%

ONC

$319.97

3.73%

INSM

$189.70

2.17%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto su Reuters